Diet and Multiple Sclerosis

A healthy and balanced diet is essential for controlling diseases such as multiple scelrosis. Here are the latest discoveries pertaining to diet and this disease.

May 11, 2020

The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder

Multiple Sclerosis and Related Disorders
Nasim RezaeimaneshAbdorreza Naser Moghadasi
April 3, 2020
Review
Open Access

Nutrition, IBD and Gut Microbiota: A Review

Nutrients
Maria Chiara MentellaGiacinto Abele Donato Miggiano
June 12, 2020
Open Access

Influence of physical activity on serum vitamin D levels in people with multiple sclerosis

PloS One
Angelika BauerFlorian Deisenhammer
June 13, 2020
Open Access

Aggressive multiple sclerosis (2): Treatment

Multiple Sclerosis : Clinical and Laboratory Research
Georgina Arrambide2018 ECTRIMS Focused Workshop Group
May 15, 2020

Dietary factors in experimental autoimmune encephalomyelitis and multiple sclerosis: A comprehensive review

Multiple Sclerosis : Clinical and Laboratory Research
Claire ValburgAsaff Harel
May 12, 2020
Review

12th Post-ECTRIMS Meeting: review of the novelties from the 2019 ECTRIMS Congress (I)

Revista de neurologia
O FernándezA Rodríguez-Antigüedad
June 23, 2020

Sense and nonsense concerning biotin interference in laboratory tests

Acta Clinica Belgica
Alena Moerman, Joris R Delanghe
May 22, 2020
Review
Open Access

A Brief Review of the Effects of Vitamin D on Multiple Sclerosis

Frontiers in Immunology
Andrei MicleaRobert Hoepner
April 7, 2020

Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies

Multiple Sclerosis : Clinical and Laboratory Research
Lazaros BelbasisIoanna Tzoulaki
April 18, 2020

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT

Neurology
Marianna CorteseBENEFIT Study Group
May 29, 2020
Preprint
Open Access

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis through Immunophenotyping

MedRxiv : the Preprint Server for Health Sciences
P. HannikainenBibiana Bielekova
June 4, 2020

SF-6D health state utilities for lifestyle, sociodemographic and clinical characteristics of a large international cohort of people with multiple sclerosis

Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
Julie A CampbellSteve Simpson-Yap
May 5, 2020

Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019)

Multiple Sclerosis : Clinical and Laboratory Research
Jan D LünemannCelia Oreja-Guevara
April 4, 2020

Serum levels of matrix metalloproteinase-2, -9, and vitamin D in patients with multiple sclerosis with or without herpesvirus-6 seropositivity

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
Razieh AminiFarid Azizi Jalilian
May 20, 2020
Review

Dietary interventions for multiple sclerosis-related outcomes

The Cochrane Database of Systematic Reviews
Natalie E ParksBradley C Johnston

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/diet-and-multiple-sclerosis/f49fbffa-6fb8-49b1-bdb2-aadeb11adc0d